Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWake Forest University Health Sciences
About this trial
The purpose of this research study is to test the accuracy of the Dexcom continuous glucose monitoring device during the cardiothoracic surgical procedure and recovery period in the Cardiac Intensive Care Unit. Readings from the device will be compared with the standard of care blood glucose levels that are obtained during your surgery and postoperatively.
Eligibility criteria
Qualifiers
18 years of age or older
Undergoing cardiac surgery with cardiopulmonary bypass at Atrium Health Wake Forest Baptist Medical Center
Disqualifiers
Under 18 years of age
Pregnant women
Patients with a contraindication to device placement on the posterior arm, including rash, missing extremity, or existing line or device
Trial design
Treatments tested in this trial
- Dexcom G7 Continuous Glucose Monitor
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov